Jeonjinbio Co. Ltd (110020) — Financial Flexibility Index
Jeonjinbio Co. Ltd (110020) has a Financial Flexibility Index of 0.25x as of September 2025. Free cash flow of ₩323.26 Million (operating CF ₩313.21 Million minus capex ₩10.04 Million) represents 0% of total liabilities (₩1.27 Billion). Check Jeonjinbio Co. Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jeonjinbio Co. Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Jeonjinbio Co. Ltd across 10 annual periods. See Jeonjinbio Co. Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jeonjinbio Co. Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for Jeonjinbio Co. Ltd. For the full company profile including market capitalisation, see Jeonjinbio Co. Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.85x | ₩3.40 Billion | ₩3.01 Billion | ₩1.19 Billion | ▲ +8728.1% |
| 2023 | 0.03x | ₩371.04 Million | ₩-300.60 Million | ₩11.48 Billion | ▲ +117.1% |
| 2022 | -0.19x | ₩-1.58 Billion | ₩-3.71 Billion | ₩8.36 Billion | ▼ -487.3% |
| 2021 | -0.03x | ₩-451.59 Million | ₩-2.38 Billion | ₩14.02 Billion | ▼ -106.8% |
| 2020 | 0.47x | ₩3.49 Billion | ₩-2.31 Billion | ₩7.41 Billion | ▲ +376.3% |
| 2019 | -0.17x | ₩-598.32 Million | ₩-1.30 Billion | ₩3.51 Billion | ▲ +74.4% |
| 2018 | -0.67x | ₩-2.13 Billion | ₩-2.16 Billion | ₩3.21 Billion | ▼ -519.7% |
| 2017 | -0.11x | ₩-410.76 Million | ₩-413.19 Million | ₩3.83 Billion | ▼ -1050.2% |
| 2016 | -0.01x | ₩-33.11 Million | ₩-181.90 Million | ₩3.55 Billion | ▲ +96.0% |
| 2015 | -0.23x | ₩-1.84 Billion | ₩-1.95 Billion | ₩7.95 Billion | — |